184 related articles for article (PubMed ID: 1507356)
1. Plasma and urine glycolate assays for differentiating the hyperoxaluria syndromes.
Marangella M; Petrarulo M; Vitale C; Cosseddu D; Linari F
J Urol; 1992 Sep; 148(3 Pt 2):986-9. PubMed ID: 1507356
[TBL] [Abstract][Full Text] [Related]
2. Plasma and urinary oxalate and glycolate in healthy subjects.
Hagen L; Walker VR; Sutton RA
Clin Chem; 1993 Jan; 39(1):134-8. PubMed ID: 8419038
[TBL] [Abstract][Full Text] [Related]
3. Urinary oxalate and glycolate excretion in healthy infants and children.
Leumann EP; Dietl A; Matasovic A
Pediatr Nephrol; 1990 Sep; 4(5):493-7. PubMed ID: 2242313
[TBL] [Abstract][Full Text] [Related]
4. Glycolate determination detects type I primary hyperoxaluria in dialysis patients.
Marangella M; Petrarulo M; Bianco O; Vitale C; Finocchiaro P; Linari F
Kidney Int; 1991 Jan; 39(1):149-54. PubMed ID: 2002628
[TBL] [Abstract][Full Text] [Related]
5. Simple, fast and inexpensive quantification of glycolate in the urine of patients with primary hyperoxaluria type 1.
Boehm T; Martin-Higueras C; Friesser E; Zitta C; Wallner S; Walli A; Kovacevic K; Hubmann H; Klavins K; Macheroux P; Hoppe B; Jilma B
Urolithiasis; 2023 Mar; 51(1):49. PubMed ID: 36920530
[TBL] [Abstract][Full Text] [Related]
6. Response to a physiologic dose of pyridoxine in type I primary hyperoxaluria.
Yendt ER; Cohanim M
N Engl J Med; 1985 Apr; 312(15):953-7. PubMed ID: 3974685
[TBL] [Abstract][Full Text] [Related]
7. Urinary oxalate and glycolate excretion and plasma oxalate concentration.
Barratt TM; Kasidas GP; Murdoch I; Rose GA
Arch Dis Child; 1991 Apr; 66(4):501-3. PubMed ID: 2031609
[TBL] [Abstract][Full Text] [Related]
8. Endogenous Oxalate Production in Primary Hyperoxaluria Type 1 Patients.
Garrelfs SF; van Harskamp D; Peters-Sengers H; van den Akker CHP; Wanders RJA; Wijburg FA; van Goudoever JB; Groothoff JW; Schierbeek H; Oosterveld MJS
J Am Soc Nephrol; 2021 Dec; 32(12):3175-3186. PubMed ID: 34686543
[TBL] [Abstract][Full Text] [Related]
9. Oxalate status in stone-formers. Two distinct hyperoxaluric entities.
Hatch M
Urol Res; 1993 Jan; 21(1):55-9. PubMed ID: 8456539
[TBL] [Abstract][Full Text] [Related]
10. Hydroxyproline-induced hyperoxaluria using acidified and traditional diets in the porcine model.
Kaplon DM; Penniston KL; Darriet C; Crenshaw TD; Nakada SY
J Endourol; 2010 Mar; 24(3):355-9. PubMed ID: 20078233
[TBL] [Abstract][Full Text] [Related]
11. Derivatization and high-performance liquid chromatographic determination of urinary glycolic acid.
Petrarulo M; Pellegrino S; Bianco O; Marangella M; Linari F; Mentasti E
J Chromatogr; 1989 Mar; 465(1):87-93. PubMed ID: 2708493
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyproline ingestion and urinary oxalate and glycolate excretion.
Knight J; Jiang J; Assimos DG; Holmes RP
Kidney Int; 2006 Dec; 70(11):1929-34. PubMed ID: 17021603
[TBL] [Abstract][Full Text] [Related]
13. The urinary response to an oral oxalate load in recurrent calcium stone formers.
Krishnamurthy MS; Hruska KA; Chandhoke PS
J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
[TBL] [Abstract][Full Text] [Related]
14. Two-carbon oxalogenesis compared in recurrent calcium oxalate stone formers and normal subjects.
McWhinney BC; Nagel SL; Cowley DM; Brown JM; Chalmers AH
Clin Chem; 1987 Jul; 33(7):1118-20. PubMed ID: 3594837
[TBL] [Abstract][Full Text] [Related]
15. The effect of pyridoxine on oxalate dynamics in three cases of primary hyperoxaluria (with glycollic aciduria).
Watts RW; Veall N; Purkiss P; Mansell MA; Haywood EF
Clin Sci (Lond); 1985 Jul; 69(1):87-90. PubMed ID: 4064559
[TBL] [Abstract][Full Text] [Related]
16. Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1: A Placebo-Controlled Randomized Clinical Trial.
Frishberg Y; Deschênes G; Groothoff JW; Hulton SA; Magen D; Harambat J; Van't Hoff WG; Lorch U; Milliner DS; Lieske JC; Haslett P; Garg PP; Vaishnaw AK; Talamudupula S; Lu J; Habtemariam BA; Erbe DV; McGregor TL; Cochat P;
Clin J Am Soc Nephrol; 2021 Jul; 16(7):1025-1036. PubMed ID: 33985991
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic expression of primary hyperoxaluria: comparative features of types I and II.
Milliner DS; Wilson DM; Smith LH
Kidney Int; 2001 Jan; 59(1):31-6. PubMed ID: 11135054
[TBL] [Abstract][Full Text] [Related]
18. Plasma oxalate level in pediatric calcium stone formers with or without secondary hyperoxaluria.
Sikora P; Beck B; Zajaczkowska M; Hoppe B
Urol Res; 2009 Apr; 37(2):101-5. PubMed ID: 19183975
[TBL] [Abstract][Full Text] [Related]
19. Alanine glyoxylate aminotransferase and the urinary excretion of oxalate and glycollate in hyperoxaluria type I and the Zellweger syndrome.
Wanders RJ; van Roermund CW; Westra R; Schutgens RB; van der Ende MA; Tager JM; Monnens LA; Baadenhuysen H; Govaerts L; Przyrembel H
Clin Chim Acta; 1987 Jun; 165(2-3):311-9. PubMed ID: 3652453
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity to meat protein intake and hyperoxaluria in idiopathic calcium stone formers.
Nguyen QV; Kälin A; Drouve U; Casez JP; Jaeger P
Kidney Int; 2001 Jun; 59(6):2273-81. PubMed ID: 11380831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
